300396 迪瑞医疗
午间休市 08-01 11:30:00
资讯
新帖
简况
迪瑞医疗：公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、销售与服务
证券之星 · 07-28
迪瑞医疗：公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、销售与服务
迪瑞医疗：本次董事变更不涉及重组事宜
证券之星 · 07-28
迪瑞医疗：本次董事变更不涉及重组事宜
迪瑞医疗：公司信息披露工作严格按照法律法规要求进行
证券之星 · 07-08
迪瑞医疗：公司信息披露工作严格按照法律法规要求进行
迪瑞医疗：公司将继续踏实做好主业努力最大化创造价值回报股东
证券之星 · 06-11
迪瑞医疗：公司将继续踏实做好主业努力最大化创造价值回报股东
迪瑞医疗：公司将努力提升市场对公司价值认同与信心
证券之星 · 06-11
迪瑞医疗：公司将努力提升市场对公司价值认同与信心
迪瑞医疗：经与股东方沟通了解目前正在办理延期手续具体请您留意后续公开信息
证券之星 · 06-04
迪瑞医疗：经与股东方沟通了解目前正在办理延期手续具体请您留意后续公开信息
迪瑞医疗：公司经营范围新增兽医专用器械销售内容
证券之星 · 05-20
迪瑞医疗：公司经营范围新增兽医专用器械销售内容
迪瑞医疗收盘上涨2.10%，滚动市盈率103.52倍，总市值37.06亿元
金融界 · 05-16
迪瑞医疗收盘上涨2.10%，滚动市盈率103.52倍，总市值37.06亿元
迪瑞医疗：公司始终重视市值管理，将根据市场环境变化及公司实际情况优化策略
证券之星 · 05-14
迪瑞医疗：公司始终重视市值管理，将根据市场环境变化及公司实际情况优化策略
迪瑞医疗(300396.SZ)：恒健国际拟减持不超3%股份
格隆汇 · 05-08
迪瑞医疗(300396.SZ)：恒健国际拟减持不超3%股份
迪瑞医疗最新公告：股东拟减持不超过3%公司股份
证券之星 · 05-08
迪瑞医疗最新公告：股东拟减持不超过3%公司股份
迪瑞医疗：公司管理层一直致力于做好生产经营工作以提升企业内在价值
证券之星 · 04-30
迪瑞医疗：公司管理层一直致力于做好生产经营工作以提升企业内在价值
迪瑞医疗：公司将会持续提升公司内在价值和稳定经营等方面积极布局
证券之星 · 04-30
迪瑞医疗：公司将会持续提升公司内在价值和稳定经营等方面积极布局
迪瑞医疗(300396)3月31日股东户数1.79万户，较上期减少1.16%
证券之星 · 04-26
迪瑞医疗(300396)3月31日股东户数1.79万户，较上期减少1.16%
迪瑞医疗(300396.SZ)发布一季度业绩，归母净利润1567.87万元，下降87.13%
智通财经 · 04-25
迪瑞医疗(300396.SZ)发布一季度业绩，归母净利润1567.87万元，下降87.13%
迪瑞医疗收盘下跌1.11%，滚动市盈率25.71倍，总市值36.49亿元
金融界 · 04-24
迪瑞医疗收盘下跌1.11%，滚动市盈率25.71倍，总市值36.49亿元
迪瑞医疗：公司长期稳健的发展离不开资本市场的助力和广大投资者的支持
证券之星 · 04-17
迪瑞医疗：公司长期稳健的发展离不开资本市场的助力和广大投资者的支持
迪瑞医疗：公司技术与产品应用情况，请以公司定期报告等相关公告为准
证券之星 · 03-05
迪瑞医疗：公司技术与产品应用情况，请以公司定期报告等相关公告为准
迪瑞医疗：您的意见已经收到，期待您持续关注迪瑞医疗
证券之星 · 03-03
迪瑞医疗：您的意见已经收到，期待您持续关注迪瑞医疗
迪瑞医疗：您好投资者！您的意见已收悉。感谢您对公司的关注及良好建议
证券之星 · 02-25
迪瑞医疗：您好投资者！您的意见已收悉。感谢您对公司的关注及良好建议
加载更多
公司概况
公司名称：
迪瑞医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2014-09-10
主营业务：
迪瑞医疗科技股份有限公司的主营业务是医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。公司的主要产品是尿液分析、生化分析、化学发光免疫分析、妇科分泌物分析、血细胞分析、凝血分析、整体化实验室。公司获得的专利213项，其中发明专利136项；已获得软件著作权96项。
发行价格：
29.54
{"stockData":{"symbol":"300396","market":"SZ","secType":"STK","nameCN":"迪瑞医疗","latestPrice":14.84,"timestamp":1754022876000,"preClose":14.6,"halted":0,"volume":5094280,"delay":0,"changeRate":0.0164,"floatShares":272000000,"shares":273000000,"eps":0.1313,"marketStatus":"午间休市","change":0.24,"latestTime":"08-01 11:30:00","open":14.53,"high":14.95,"low":14.48,"amount":75578500,"amplitude":0.0322,"askPrice":14.84,"askSize":30,"bidPrice":14.83,"bidSize":115,"shortable":0,"etf":0,"ttmEps":0.1313,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754024400000},"marketStatusCode":3,"adr":0,"adjPreClose":14.6,"symbolType":"stock","openAndCloseTimeList":[[1754011800000,1754019000000],[1754024400000,1754031600000]],"highLimit":16.06,"lowLimit":13.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":272700161,"isCdr":false,"pbRate":1.92,"roa":"--","peRate":113.02361,"roe":"0.76%","epsLYR":0.52,"committee":0.784802,"marketValue":4047000000,"turnoverRate":0.0187,"status":0,"floatMarketCap":4043000000},"requestUrl":"/m/hq/s/300396","defaultTab":"news","newsList":[{"id":"2554724434","title":"迪瑞医疗：公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、销售与服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724434?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:01","pubTimestamp":1753693262,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，广东佛山出现蚊子疫情，作为体外检测公司，公司能为防控和检查疫情工作添砖加瓦，出一份社会责任和担当吗？迪瑞医疗回复：公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、销售与服务，公司将持续关注公共卫生需求，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800022361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159891","300396","BK0077","BK0028"],"gpt_icon":0},{"id":"2554724258","title":"迪瑞医疗：本次董事变更不涉及重组事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724258?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:01","pubTimestamp":1753693261,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：希望华润集团对迪瑞医疗重组成功，对投资者的回报迪瑞医疗回复：本次董事变更不涉及重组事宜，公司相关情况请以公告为准，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800022359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2549512380","title":"迪瑞医疗：公司信息披露工作严格按照法律法规要求进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2549512380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549512380?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:54","pubTimestamp":1751964879,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，华润7月27日到期了，剩下不到20天，过户完成快点出公告迪瑞医疗回复：公司信息披露工作严格按照法律法规要求进行，感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800027081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300396","BK0077"],"gpt_icon":0},{"id":"2542309774","title":"迪瑞医疗：公司将继续踏实做好主业努力最大化创造价值回报股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2542309774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542309774?lang=zh_cn&edition=full","pubTime":"2025-06-11 17:01","pubTimestamp":1749632477,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，太羡慕三九的分红，迪瑞什么时候像三九那样迪瑞医疗回复：感谢关注！公司将继续踏实做好主业，不断提升自身经营能力和核心竞争力，实施持续、稳定的利润分配政策，努力最大化创造价值回报股东。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100025583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300396","BK0077"],"gpt_icon":0},{"id":"2542708309","title":"迪瑞医疗：公司将努力提升市场对公司价值认同与信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2542708309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542708309?lang=zh_cn&edition=full","pubTime":"2025-06-11 17:01","pubTimestamp":1749632464,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，新产品成功上市要公布出来，你们有什么节日都准时发布，这些有什么用，一年研发出新品太少了，研发团队让投资者担优迪瑞医疗回复：公司将努力提升市场对公司价值认同与信心，继续围绕主业，坚持科技创新，积极开发新产品、开拓新客户，努力提升公司内在价值，回报投资者。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100025578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2540030688","title":"迪瑞医疗：经与股东方沟通了解目前正在办理延期手续具体请您留意后续公开信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2540030688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540030688?lang=zh_cn&edition=full","pubTime":"2025-06-04 16:25","pubTimestamp":1749025518,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，请如实回答，华润欣德是不是投资迪瑞到2025年7月27日到期，是吗迪瑞医疗回复：您好！经与股东方沟通了解，目前正在办理延期手续，具体请您留意后续公开信息。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400024002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","BK0028","300396"],"gpt_icon":0},{"id":"2536444694","title":"迪瑞医疗：公司经营范围新增兽医专用器械销售内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2536444694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536444694?lang=zh_cn&edition=full","pubTime":"2025-05-20 17:03","pubTimestamp":1747731825,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司是否有涉及宠物经济吗？谢谢迪瑞医疗回复：您好投资者！公司的经营范围中新增加了兽医专用器械销售内容。此外，公司在动物检测产线推出BF-6900VET全自动五分类动物血细胞分析仪，HC-300VET干化学尿液分析仪及配套试剂等产品，逐步构建动物体液检测的整体解决方案。具体对业绩带动存在不确定性，请以公司公告为准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052000026030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0077","BK0028"],"gpt_icon":0},{"id":"2535368040","title":"迪瑞医疗收盘上涨2.10%，滚动市盈率103.52倍，总市值37.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535368040","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535368040?lang=zh_cn&edition=full","pubTime":"2025-05-16 17:11","pubTimestamp":1747386662,"startTime":"0","endTime":"0","summary":"5月16日，迪瑞医疗今日收盘13.59元，上涨2.10%，滚动市盈率PE达到103.52倍，总市值37.06亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均49.40倍，行业中值36.13倍，迪瑞医疗排名第106位。资金流向方面，5月16日，迪瑞医疗主力资金净流入684.22万元，近5日总体呈流入状态，5日共流入89.53万元。最新一期业绩显示，2025年一季报，公司实现营业收入1.82亿元，同比-72.47%；净利润1567.87万元，同比-87.13%，销售毛利率42.78%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16171150449774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300396","BK0028","BK0077","BK0251"],"gpt_icon":0},{"id":"2535156200","title":"迪瑞医疗：公司始终重视市值管理，将根据市场环境变化及公司实际情况优化策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2535156200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535156200?lang=zh_cn&edition=full","pubTime":"2025-05-14 16:24","pubTimestamp":1747211055,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董事长作为一个有良知的企业，既然上市了，你的市值管理行动在哪里？迪瑞医疗回复：感谢您对公司发展的持续关注。公司始终重视市值管理，将根据市场环境变化及公司实际情况，定期审视并优化市值管理策略。当前受市场环境和短期业绩影响，股价表现不佳，向关心和支持公司发展的投资者表示歉意。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400025451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0077","BK0028"],"gpt_icon":0},{"id":"2533824501","title":"迪瑞医疗(300396.SZ)：恒健国际拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533824501","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533824501?lang=zh_cn&edition=full","pubTime":"2025-05-08 20:19","pubTimestamp":1746706753,"startTime":"0","endTime":"0","summary":"格隆汇5月8日丨迪瑞医疗(300396.SZ)公布，持有公司股份33,123,600股(占公司总股本比例12.15%)的股东广东恒健国际投资有限公司(以下简称“恒健国际”)计划以竞价或大宗交易方式减持公司股份总数不超过8,148,270股，减持比例不超过公司总股本3%，自减持计划公告之日起十五个交易日后的90日内实施。其中通过竞价方式减持的，任意连续90个自然日内减持公司股份总数不超过2,710,630股，减持比例不超过公司总股本的1%；通过大宗交易方式减持的，任意连续90个自然日内减持公司股份不超过5,437,640股，减持比例不超过公司总股本的2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/08201950238000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0251","BK0077","300396"],"gpt_icon":0},{"id":"2533181861","title":"迪瑞医疗最新公告：股东拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533181861","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533181861?lang=zh_cn&edition=full","pubTime":"2025-05-08 19:49","pubTimestamp":1746704998,"startTime":"0","endTime":"0","summary":"迪瑞医疗(300396.SZ)公告称，持股12.15%的股东恒健国际计划以竞价或大宗交易方式减持公司股份总数不超过8,148,270股，减持比例不超过公司总股本3%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050800029825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","BK0077","300396"],"gpt_icon":0},{"id":"2531770289","title":"迪瑞医疗：公司管理层一直致力于做好生产经营工作以提升企业内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2531770289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531770289?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:08","pubTimestamp":1745996899,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗04月30日在投资者关系平台上答复投资者关心的问题。感谢您对公司的发展的关切，公司管理层一直致力于做好生产经营工作以提升企业内在价值，通过持续优化业务结构、提高运营效率和盈利能力，以实现业绩稳步增长。公司将会不断地积极传递公司价值，增进市场认同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000025906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","BK0077","300396"],"gpt_icon":0},{"id":"2531177022","title":"迪瑞医疗：公司将会持续提升公司内在价值和稳定经营等方面积极布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2531177022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531177022?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:05","pubTimestamp":1745996701,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)04月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司对2025年业绩有没有好的展望？对于股价的加速下跌有没有相关的救市方案？迪瑞医疗回复：尊敬的投资者，感谢您对公司的关注，公司管理层高度重视公司经营情况及公司市值表现，但二级市场股价表现受多种因素影响，公司将会持续提升公司内在价值和稳定经营等方面积极布局，努力提升公司投资价值。如后续有相关计划，公司将按规定及时履行信息披露义务。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000025834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0077","BK0028","BK0251"],"gpt_icon":0},{"id":"2530144710","title":"迪瑞医疗(300396)3月31日股东户数1.79万户，较上期减少1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530144710","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530144710?lang=zh_cn&edition=full","pubTime":"2025-04-26 17:14","pubTimestamp":1745658899,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迪瑞医疗披露，截至2025年3月31日公司股东户数为1.79万户，较2月28日减少209.0户，减幅为1.16%。在医疗器械行业个股中，迪瑞医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.09万户。从股价来看，2025年2月28日至2025年3月31日，迪瑞医疗区间跌幅为5.44%，在此期间股东户数减少209.0户，减幅为1.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600012033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2530413920","title":"迪瑞医疗(300396.SZ)发布一季度业绩，归母净利润1567.87万元，下降87.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530413920","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530413920?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:44","pubTimestamp":1745588649,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪瑞医疗(300396.SZ)发布2025年第一季度报告，该公司营业收入为1.82亿元，同比减少72.47%。归属于上市公司股东的净利润为1567.87万元，同比减少87.13%。归属于上市公司股东的扣除非经常性损益的净利润为1396.9万元，同比减少88.30%。基本每股收益为0.0575元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300396"],"gpt_icon":0},{"id":"2529067421","title":"迪瑞医疗收盘下跌1.11%，滚动市盈率25.71倍，总市值36.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529067421","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529067421?lang=zh_cn&edition=full","pubTime":"2025-04-24 17:26","pubTimestamp":1745486790,"startTime":"0","endTime":"0","summary":"4月24日，迪瑞医疗今日收盘13.38元，下跌1.11%，滚动市盈率PE达到25.71倍，总市值36.49亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均46.75倍，行业中值29.99倍，迪瑞医疗排名第64位。股东方面，截至2025年2月28日，迪瑞医疗股东户数18086户，较上次减少1477户，户均持股市值35.28万元，户均持股数量2.76万股。迪瑞医疗科技股份有限公司的主营业务是医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/24172649830219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2528793704","title":"迪瑞医疗：公司长期稳健的发展离不开资本市场的助力和广大投资者的支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2528793704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528793704?lang=zh_cn&edition=full","pubTime":"2025-04-17 17:36","pubTimestamp":1744882566,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)04月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，开股东大会，所有投资者用脚投票迪瑞医疗回复：投资者您好！公司长期稳健的发展离不开资本市场的助力和广大投资者的支持，公司也特别希望能让投资者共享公司发展成果。后续公司也会根据实际情况积极探索其他有效措施提升公司价值，增强投资者信心。感谢关注！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041700026903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300396","BK0077"],"gpt_icon":0},{"id":"2517960520","title":"迪瑞医疗：公司技术与产品应用情况，请以公司定期报告等相关公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517960520?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:31","pubTimestamp":1741163487,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)03月05日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司有涉及AI医疗吗？麻烦请回答有或没有就行，其他客套话就不要说了，谢谢迪瑞医疗回复：感谢您的关注！公司技术与产品应用情况，请以公司定期报告等相关公告为准，谢谢！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500027846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300396","BK0077"],"gpt_icon":0},{"id":"2516826896","title":"迪瑞医疗：您的意见已经收到，期待您持续关注迪瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2516826896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516826896?lang=zh_cn&edition=full","pubTime":"2025-03-03 19:30","pubTimestamp":1741001423,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)03月03日在投资者关系平台上答复投资者关心的问题。投资者：国提倡央企AI行动计划，公司是否考虑投入考虑引入AI智能技术？迪瑞医疗董秘：感谢您的关注，您的意见已经收到，期待您持续关注迪瑞医疗。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300028702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2514667660","title":"迪瑞医疗：您好投资者！您的意见已收悉。感谢您对公司的关注及良好建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514667660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514667660?lang=zh_cn&edition=full","pubTime":"2025-02-25 18:00","pubTimestamp":1740477654,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)02月25日在投资者关系平台上答复投资者关心的问题。投资者：董秘，2024年医疗器械上市公司几乎都有跟国外大公司和国内大公司合作，只有迪瑞没有，是不是单打独斗做头部企业，迪瑞的产品如果没有改革创新，跟上大时代，会被社会淘汰的迪瑞医疗董秘：您好投资者！您的意见已收悉。感谢您对公司的关注及良好建议。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500033571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","BK0077","300396"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754022933897,"stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0429},{"period":"3month","weight":0.145},{"period":"6month","weight":0.001},{"period":"1year","weight":-0.1039},{"period":"ytd","weight":-0.089}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0334},{"period":"3month","weight":0.0897},{"period":"6month","weight":0.0992},{"period":"1year","weight":0.2159},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迪瑞医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"17877人(较上一季度减少1.16%)","perCapita":"15240股","listingDate":"2014-09-10","address":"吉林省长春市朝阳区高新技术产业开发区云河街95号","registeredCapital":"27270万元","survey":" 迪瑞医疗科技股份有限公司的主营业务是医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。公司的主要产品是尿液分析、生化分析、化学发光免疫分析、妇科分泌物分析、血细胞分析、凝血分析、整体化实验室。公司获得的专利213项，其中发明专利136项；已获得软件著作权96项。","listedPrice":29.54},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪瑞医疗(300396)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪瑞医疗(300396)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪瑞医疗,300396,迪瑞医疗股票,迪瑞医疗股票老虎,迪瑞医疗股票老虎国际,迪瑞医疗行情,迪瑞医疗股票行情,迪瑞医疗股价,迪瑞医疗股市,迪瑞医疗股票价格,迪瑞医疗股票交易,迪瑞医疗股票购买,迪瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪瑞医疗(300396)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪瑞医疗(300396)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}